|Question and Answer Panel
- Are we curing AL amyloidosis in 2020?
- Is there a role for MRD assessment?
- When to suspect AL amyloidosis during MGUS follow-up?
- What is the real prevalence of wild type ATTR amyloidosis?
- Amyloid deposition in organ transplant recipients
- Best treatment approach at lack of response to patisiran or inotersen in ATTR
- Is it time for combination therapy trials in ATTR?
- Is there a role for anti-amyloid therapy? (anti-SAP, doxycycline, others)
|Clinical Trials in Progress in Systemic Amyloidosis|